Ers 2008, mae merched 12 neu 13 oed wedi cael cynnig y brechlyn HPV ledled y DU i helpu i ddiogelu rhag canser ceg y groth. Mae ymchwil galonogol wedi dangos bod y brechlyn wedi arwain at ostyngiad o tua 90% yn nifer y bobl sydd â chelloedd cyn-ganseraidd. Mae'r cyfuniad o imiwneiddio a phrofion sgrinio serfigol yn cynnig yr amddiffyniad gorau posibl rhag canser ceg y groth, a disgwyliwn weld gostyngiad sylweddol mewn achosion o ganser ceg y groth yn y dyfodol agos.
Since 2008, girls aged 12 or 13 have been offered the HPV vaccine across the UK to help protect against cervical cancer. Encouraging research has shown that the vaccine has led to about a 90% reduction in the number of people with pre-cancerous cells. The combination of immunisation and cervical screening offers the best possible protection against cervical cancer and we expect to see a significant decline in cervical cancers in the near future.